ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646161 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646161; 2) Community: the network communities that were significantly associated with the response to NSC 646161; 3) Molecule: the relationships between components within communities and NSC 646161; 4) MDR: the compounds that were significantly associated with the NSC 646161.

NSC Compound Enrichment Correlation
NSC 743432 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.00770426557728506 0.51970263
NSC 665522 Null 0.00803384002766638 0.43615831
NSC 668325 Null 0.00803384002766638 0.61897272
NSC 670784 Null 0.00803384002766638 0.53818275
NSC 733755 Null 0.00803384002766638 0.34853589
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.00803384002766641 -0.38103199
NSC 625544 Null 0.00803384002766641 0.65005666
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.00803384002766641 0.54088965
NSC 627666 1H-Benzo[de]-1,3-benzodioxolo[5,6]quinoline-6a- carbonitrile, 6-benzoyl-1,2-dimethoxy- 0.00803384002766641 -0.38755576
NSC 631136 Benzoxazole, 2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.00803384002766641 0.5620594
Total:100  Current:33    [First] [Prev] [Next] [Last]